JP Morgan Initiates Coverage On Savara with Overweight Rating, Announces Price Target of $12

10/7/2026
Impact: 85
Healthcare

JP Morgan analyst Caroline Pocher has initiated coverage on Savara (NASDAQ: SVRA) with an Overweight rating and set a price target of $12 for the stock. This marks a positive outlook for the company as it begins to attract analyst attention.

AI summary, not financial advice

Share: